Current Practices in the Pathologic Assessment of Breast Tissue in Transmasculine Chest Surgery.

Plastic and reconstructive surgery 2022 Vol.150(3) p. 516e-525e

Goodwin IA, Luo J, Magno-Pardon DA, Veith J, Willcockson J, Carter G, Matsen C, Kwok AC, Agarwal CA

관련 도메인

Abstract

[BACKGROUND] No guidelines exist regarding management of breast tissue for transmasculine and gender-nonconforming individuals. This study aims to investigate the experiences and practices regarding perioperative breast cancer risk management among the American Society of Plastic Surgeons members performing chest masculinization surgery.

[METHODS] An anonymous, online, 19-question survey was sent to 2517 U.S.-based American Society of Plastic Surgeons members in October of 2019.

[RESULTS] A total of 69 responses were analyzed. High-volume surgeons were more likely from academic centers (OR, 4.88; 95 percent CI, 1.67 to 15.22; p = 0.005). Age older than 40 years [ n = 59 (85.5 percent)] and family history of breast cancer in first-degree relatives [ n = 47 (68.1 percent)] or family with a diagnosis before age 40 [ n = 49 (71.0 percent)] were the most common indications for preoperative imaging. Nineteen of the respondents (27.5 percent) routinely excise all macroscopic breast tissue, with 21 (30.4 percent) routinely leaving breast tissue. Fifty-one respondents (73.9 percent) routinely send specimens for pathologic analysis. There was no significant correlation between surgical volume or type of practice and odds of sending specimens for pathologic analysis. High patient costs and patient reluctance [ n = 27 (39.1 percent) and n = 24 (35.3 percent), respectively] were the most often cited barriers for sending specimens for pathologic analysis. Six respondents (8.7 percent) have found malignant or premalignant lesions in masculinizing breast specimens.

[CONCLUSIONS] Large variation was found among surgeons' perioperative management of chest masculinizing surgery patients regarding preoperative cancer screening, pathologic assessment of resected tissue, and postoperative cancer surveillance. Standardization of care and further studies are needed to document risk, incidence, and prevalence of breast cancer in the transmasculine population before and after surgery.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
해부 breast 유방 dict 8
해부 breast tissue scispacy 1
해부 specimens scispacy 1
해부 tissue scispacy 1
합병증 premalignant lesions scispacy 1
약물 Transmasculine scispacy 1
약물 [BACKGROUND] scispacy 1
약물 [RESULTS] A scispacy 1
약물 [CONCLUSIONS] Large scispacy 1
질환 breast cancer C0006142
Malignant neoplasm of breast
scispacy 1
질환 first-degree relatives [ n = 47 (68.1 percent)] or family with a diagnosis before age 40 [ n = 49 (71.0 percent)] were the most common indications for preoperative imaging. scispacy 1
질환 cancer C0006826
Malignant Neoplasms
scispacy 1
질환 postoperative cancer scispacy 1
질환 Breast Tissue scispacy 1
질환 specimens scispacy 1
질환 masculinizing breast specimens scispacy 1
기타 patient scispacy 1
기타 patients scispacy 1

MeSH Terms

Adult; Breast Neoplasms; Early Detection of Cancer; Female; Humans; Practice Patterns, Physicians'; Surgeons; Surgery, Plastic; Surveys and Questionnaires; United States

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문